Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03313804
Title Priming Immunotherapy in Advanced Disease With Radiation
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors John L. Villano, MD, PhD
Indications

lung non-small cell carcinoma

head and neck squamous cell carcinoma

Therapies

Pembrolizumab

Atezolizumab

Nivolumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.